Home
About
Science
Pipeline
- Pipeline
- Clinical Trials
Patients
Careers
Investors
Contact

Recent Posts

SDBJ: Artiva Raises $300M to Fund Phase 3 Trial for RA Cell Therapy
Biotech2050 Podcast: Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
Base to Base Biotech Podcast: Natural Killer Cell Therapy
SDBJ: Artiva Bio Soaring on Focus Shift from Oncology to Autoimmune Disease
Inside Precision Medicine: Asked & Answered with Artiva’s CMO Dr. Subhashis Banerjee

Archives

May 2026
March 2026
January 2026
November 2025
June 2025
April 2025
March 2025
February 2025
January 2025
November 2024
August 2024
May 2024
April 2024
March 2024
February 2024
December 2023
November 2023

Categories

Artiva In the News

Archives

May 2026
March 2026
January 2026
November 2025
June 2025
April 2025
March 2025
February 2025
January 2025
November 2024
August 2024
May 2024
April 2024
March 2024
February 2024
December 2023
November 2023

Category: Advisors

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Contact

Privacy Policy
Terms

© Artiva Biotherapeutics, Inc., 2026

Sign up for news updates

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy Policy